221 Repurposing dasatinib for diffuse large B cell lymphoma.
https://www.pnas.org/content/116/34/16981
220 Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes.
https://www.nature.com/articles/s41586-019-1315-z
219 Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease.
https://www.nejm.org/doi/full/10.1056/NEJMoa1903076?query=featured_home
218 1,4-Benzoquinone antimicrobial agents against Staphylococcus aureus and Mycobacterium tuberculosis derived from scorpion venom.
https://www.pnas.org/content/116/26/12642
217 Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics.
https://stm.sciencemag.org/content/11/497/eaav1386
216 Targeting RIPK1 for the treatment of human diseases.
https://www.pnas.org/content/116/20/9714
215 Molecular dissection of box jellyfish venom cytotoxicity highlights an effective venom antidote.
https://www.nature.com/articles/s41467-019-09681-1
214 Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(19)30067-1
213 Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism.
https://www.pnas.org/content/116/8/3072
212 Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells.
http://advances.sciencemag.org/content/5/2/eaav5590
211 Pharmaceutical diversification via palladium oxidative addition complexes.
http://science.sciencemag.org/content/363/6425/405
210 AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis.
https://www.pnas.org/content/116/4/1414
209 Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
http://www.pnas.org/content/115/45/11597
208 An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse.
http://advances.sciencemag.org/content/4/10/eaat4751
207 On-demand manufacturing of clinical-quality biopharmaceuticals.
https://www.nature.com/articles/nbt.4262
206 Amycomicin is a potent and specific antibiotic discovered with a targeted interaction screen.
http://www.pnas.org/content/115/40/10124
205 Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.
http://stm.sciencemag.org/content/10/460/eaat7520
204 Optimized arylomycins are a new class of Gram-negative antibiotics.
https://www.nature.com/articles/s41586-018-0483-6
203 A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.
http://stm.sciencemag.org/content/10/456/eaar3483
202 Suppression of Staphylococcus aureus virulence by a small-molecule compound.
http://www.pnas.org/content/115/31/8003
|
